HK1121165A1 - Regulatable fusion promoters - Google Patents

Regulatable fusion promoters

Info

Publication number
HK1121165A1
HK1121165A1 HK09100438.1A HK09100438A HK1121165A1 HK 1121165 A1 HK1121165 A1 HK 1121165A1 HK 09100438 A HK09100438 A HK 09100438A HK 1121165 A1 HK1121165 A1 HK 1121165A1
Authority
HK
Hong Kong
Prior art keywords
fusion promoters
regulatable fusion
regulatable
promoters
fusion
Prior art date
Application number
HK09100438.1A
Other languages
English (en)
Inventor
Charles Stout
Original Assignee
Charles Stout
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charles Stout filed Critical Charles Stout
Publication of HK1121165A1 publication Critical patent/HK1121165A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
HK09100438.1A 2005-10-01 2009-01-16 Regulatable fusion promoters HK1121165A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72256805P 2005-10-01 2005-10-01
PCT/US2006/038154 WO2007041350A2 (en) 2005-10-01 2006-09-29 Regulatable fusion promoters

Publications (1)

Publication Number Publication Date
HK1121165A1 true HK1121165A1 (en) 2009-04-17

Family

ID=37906746

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09100438.1A HK1121165A1 (en) 2005-10-01 2009-01-16 Regulatable fusion promoters

Country Status (7)

Country Link
US (1) US20090053295A1 (xx)
EP (2) EP1943265B1 (xx)
JP (3) JP5976986B2 (xx)
AU (1) AU2006297112B2 (xx)
CA (1) CA2665080C (xx)
HK (1) HK1121165A1 (xx)
WO (1) WO2007041350A2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008543281A (ja) * 2005-06-09 2008-12-04 エイジェンシー フォー サイエンス， テクノロジー アンド リサーチ 肝臓星状細胞特異的プロモーターおよびその使用
US20070299029A1 (en) * 2005-06-09 2007-12-27 Agency For Science, Technology And Research Hepatic stellate cell specific promoter and uses thereof
ES2708944T3 (es) * 2008-09-22 2019-04-12 Dicerna Pharmaceuticals Inc Composiciones y métodos para la inhibición específica de la expresión de genes por DSRNA que tenga modificaciones
EA027693B1 (ru) * 2008-09-26 2017-08-31 Токаджен Инк. Рекомбинантный репликационно-компетентный ретровирус с цитозиндезаминазной активностью для генной терапии нарушений клеточной пролиферации
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
CA3151965A1 (en) * 2008-12-18 2010-07-15 Dicerna Pharmaceuticals, Inc. Extended dicer substrate agents and methods for the specific inhibition of gene expression
CN104884627A (zh) 2012-10-25 2015-09-02 托卡根公司 具有小型启动子盒的逆转录病毒载体
EA201890640A1 (ru) 2015-09-04 2018-09-28 Токаджен Инк. Рекомбинантные векторы, содержащие пептид 2а
JP2021524467A (ja) * 2018-05-23 2021-09-13 メニスマート セラピューティクス， インコーポレイテッドＭａｎｙｓｍａｒｔ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 二重特異性ｔ細胞誘導体及びその使用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5573933A (en) 1987-04-14 1996-11-12 Luminis Pty, Ltd. Transgenic pigs
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
ATE190354T1 (de) * 1990-12-20 2000-03-15 Arch Dev Corp The University O Kontrolle der genexpression durch ionisierende strahlung
US5922854A (en) 1991-06-14 1999-07-13 Kumar; Ramesh Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
WO1993025071A1 (en) 1992-06-12 1993-12-23 Dnx Corporation Production of human hemoglobin in transgenic pigs
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
FR2738842B1 (fr) * 1995-09-15 1997-10-31 Rhone Poulenc Rorer Sa Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US6818209B1 (en) 1998-05-22 2004-11-16 Oxford Biomedica (Uk) Limited Retroviral delivery system
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
DE19751587A1 (de) * 1997-11-21 1999-07-29 Hoechst Marion Roussel De Gmbh Onkogen- oder virusgesteuerte Expressionssysteme
DE19756975A1 (de) * 1997-12-20 1999-06-24 Hoechst Marion Roussel De Gmbh Bindungspartner für Inhibitoren von cyclinabhängigen Kinasen und ihre Verwendung zur Suche nach Inhibitoren, zur Diagnose oder zur Therapie einer Erkrankung
AU762615B2 (en) * 1998-06-15 2003-07-03 Arch Development Corporation Combination of radiotherapy and anti-angiogenic factors
DE19831420A1 (de) * 1998-07-14 2000-01-20 Hoechst Marion Roussel De Gmbh Expressionssysteme enthaltend chimäre Promotoren mit Bindungsstellen für rekombinante Transkriptionsfaktoren
WO2000055335A1 (en) 1999-03-16 2000-09-21 Dana-Farber Cancer Institute, Inc. Pseudotyped lentiviral vectors and uses thereof
WO2000072886A1 (en) 1999-05-26 2000-12-07 Dana-Farber Cancer Institute, Inc. Episomally replicating lentiviral vectors
JP3704037B2 (ja) * 1999-11-05 2005-10-05 独立行政法人産業技術総合研究所 スライディング可能な機能性キメラ分子
US6579522B1 (en) * 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
JP3613576B2 (ja) * 2000-10-30 2005-01-26 独立行政法人産業技術総合研究所 細胞内で高機能な核酸分子の選択方法
JP2005504520A (ja) * 2001-06-13 2005-02-17 イースタン ヴァージニア メディカル スクール 治療用核酸の標的化発現の方法
JP4745563B2 (ja) * 2001-09-11 2011-08-10 一般財団法人 化学物質評価研究機構 レポータープラスミド
GB0130955D0 (en) * 2001-12-24 2002-02-13 Cancer Res Ventures Expression system
US6863884B2 (en) * 2002-05-01 2005-03-08 Cell Genesys, Inc. Pseudotyped retroviral vectors
US20050196862A1 (en) * 2002-08-30 2005-09-08 Wooddell Christine I. DNA cassette for cellular expression of small RNA
US6799657B2 (en) 2002-10-02 2004-10-05 Carrier Corporation Absorptive/reactive muffler for variable speed compressors
WO2004056966A2 (en) * 2002-12-18 2004-07-08 Salk Institute For Biological Studies Methods of inhibiting gene expression by rna interference
EP1583832B1 (en) * 2003-01-17 2010-12-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
US20050013018A1 (en) 2003-07-16 2005-01-20 Alex Ning Compact lens assembly
US20050130184A1 (en) * 2003-07-18 2005-06-16 University Of Massachusetts Enhanced promoters for synthesis of small hairpin RNA
US20050130919A1 (en) * 2003-07-18 2005-06-16 University Of Massachusetts Regulatable promoters for synthesis of small hairpin RNA
US20050089902A1 (en) * 2003-09-02 2005-04-28 The Scripps Research Institute Methods and compositions for siRNA expression
US20050166272A1 (en) * 2003-12-09 2005-07-28 National Institute Of Advanced Industrial Science And Technology Enhancement of RNAi activity through mutation
JP4753130B2 (ja) * 2003-12-12 2011-08-24 独立行政法人産業技術総合研究所 インターフェロン応答が軽減された長い干渉用二重鎖ｒｎａ
JPWO2005068630A1 (ja) * 2003-12-16 2007-07-26 独立行政法人産業技術総合研究所 干渉用二重鎖ｒｎａ
US20050164210A1 (en) * 2004-01-23 2005-07-28 Vivek Mittal Regulated polymerase III expression systems and related methods
US20050203047A1 (en) * 2004-03-10 2005-09-15 Ulrich Thomann Delivery vectors for short interfering RNA, micro-RNA and antisense RNA
US20050289659A1 (en) * 2004-05-18 2005-12-29 Jacks E T Cre-lox based method for conditional RNA interference
US8008468B2 (en) * 2005-02-16 2011-08-30 Benitec, Inc. RNAi expression constructs with liver-specific enhancer/promoter

Also Published As

Publication number Publication date
JP6199934B2 (ja) 2017-09-20
US20090053295A1 (en) 2009-02-26
WO2007041350A2 (en) 2007-04-12
JP5976986B2 (ja) 2016-08-24
CA2665080A1 (en) 2007-04-12
EP1943265A2 (en) 2008-07-16
CA2665080C (en) 2015-11-24
JP2012254098A (ja) 2012-12-27
EP1943265B1 (en) 2012-09-12
JP2009509544A (ja) 2009-03-12
AU2006297112B2 (en) 2013-04-18
AU2006297112A1 (en) 2007-04-12
EP2386564A1 (en) 2011-11-16
WO2007041350A3 (en) 2007-10-04
EP2386564B1 (en) 2014-07-16
EP1943265A4 (en) 2009-01-14
JP2016000047A (ja) 2016-01-07

Similar Documents

Publication Publication Date Title
IL187347A0 (en) Interferon-igg fusion
ZA200800279B (en) Apoptosis promoters
GB0519965D0 (en) Joint fusion peg
HK1121165A1 (en) Regulatable fusion promoters
ZA200806110B (en) Beverage dipensing
EP2013341A4 (en) DISEASE INDUSTRY PROMOTERS
IL196889A0 (en) Albumin-insulin fusion proteins
EP1934372A4 (en) SSB-POLYMERASE HYBRID PROTEINS
PL381408A1 (pl) Wiropłat
HK1115055A1 (en) Apoptosis promoters
EP2052790A4 (en) SCREEN
PL1858330T3 (pl) Zawiesina chwastobójcza
EP1891205A4 (en) SUSPENSION CULTURE VESSELS
IL192220A0 (en) Constitutive plant promoters
GB0508216D0 (en) Structural joint
EP1923587A4 (en) SEAL
EP1911459A4 (en) PROMOTER OF LYMPHANGIOGENESIS
GB2433078B (en) Structural member
ZA200707502B (en) Herbicidal suspension
GB0518734D0 (en) Joint
ZA200805022B (en) Joint design
GB0700759D0 (en) Novel fusion protein
GB0509332D0 (en) Joint arrangement
GB0504220D0 (en) Helicopter
PL115598U1 (en) Structural joint

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170929